Based on the Codexis Inc stock forecast from 3 analysts, the average analyst target price for Codexis Inc is USD 9.31 over the next 12 months. Codexis Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Codexis Inc is Bearish, which is based on 1 positive signals and 8 negative signals. At the last closing, Codexis Inc’s stock price was USD 3.06. Codexis Inc’s stock price has changed by -13.07% over the past week, +4.79% over the past month and +82.14% over the last year.
No recent analyst target price found for Codexis Inc
No recent average analyst rating found for Codexis Inc
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering ...Read More
Frequently Asked Questions About Codexis Inc (CDXS) Stock
Based on ratings from 3 analysts Codexis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CDXS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CDXS is USD 9.31 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on CDXS's stock to indicate if its overvalued.
The last closing price of CDXS's stock was USD 3.06.
The most recent market capitalization for CDXS is USD 0.24B.
Based on targets from 3 analysts, the average taret price for CDXS is projected at USD 9.31 over the next 12 months.
This means that CDXS's stock price may go up by +204.25% over the next 12 months.
We can't find any ETFs which contains Codexis Inc's stock.
As per our most recent records Codexis Inc has 174 Employees.
Codexis Inc's registered address is 200 Penobscot Drive, Redwood City, CA, United States, 94063.
You can get more information about it from Codexis Inc's website at https://www.codexis.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Codexis Inc (CDXS) Stock
Based on ratings from 3 analysts Codexis Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on CDXS's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for CDXS is USD 9.31 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 5.
Unfortunately we do not have enough data on CDXS's stock to indicate if its overvalued.
The last closing price of CDXS's stock was USD 3.06.
The most recent market capitalization for CDXS is USD 0.24B.
Based on targets from 3 analysts, the average taret price for CDXS is projected at USD 9.31 over the next 12 months.
This means that CDXS's stock price may go up by +204.25% over the next 12 months.
We can't find any ETFs which contains Codexis Inc's stock.
As per our most recent records Codexis Inc has 174 Employees.
Codexis Inc's registered address is 200 Penobscot Drive, Redwood City, CA, United States, 94063.
You can get more information about it from Codexis Inc's website at https://www.codexis.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CDXS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
